Background

Mr. Arthur M. Pappas, also known as Art, MBA, is a Founder, Chief executive Officer, and Managing Partner at Pappas Ventures. Mr. Pappas founded the firm in 1994. He also serves as the Chief Executive Officer at A. M. Pappas & Associates. Mr. Pappas serves as a Venture Capital Advisor at Correlation Ventures. Mr. Pappas works with a team of investment, biotechnology and medical experts who manage over $350 million and have guided the launch and development of over 55 ... life sciences companies. Prior to founding Pappas Ventures, Mr. Pappas held various senior level positions at several multinational pharmaceutical companies, for which he was responsible for the development, licensing and launch of a number of global products. Previously, he served as the founding Chief Executive Officer of CoLucid Pharmaceuticals Inc. He served as the Chief Executive Officer of Glaxo Far East (Pte) Ltd., responsible for international operations including research, development and manufacturing and Glaxo Latin America Inc. He served as a Vice President of Commercial Operations for Abbott International Ltd. and held various executive positions with Abbott Laboratories International Ltd., Merrell Dow Pharmaceuticals, and The Dow Chemical Company in the United States and internationally. He served as the Chief Executive of Glaxo Holdings plc responsible for international operations including research, development and manufacturing. He serves as the Chairman of CoLucid Pharmaceuticals, Inc. Mr. Pappas has been Director of TYRX, Inc. since February 2008. He serves as a Director of Biogen Idec Hemophilia Inc., Afferent Pharmaceuticals Inc., CeNeRx BioPharma Inc, Syndax Pharmaceuticals, Inc., Incellico, Inc., and several privately held companies. He is an observer at Balance Therapeutics. He is an Observer on the board of Selventa, Inc. and previously served as its Director. Mr. Pappas serves as a Director at GenStruct Inc., and BrainCells Inc. He has been a Director of National Venture Capital Association since May 15, 2013. And the Medical University of South Carolina Foundation for Research Development, Mr. Pappas is a Director of the North Carolina Biotechnology Center’s Board of Directors, where he served as the past Chair, and is actively involved with a variety of industry and philanthropic organizations dedicated to furthering medical research. He is a Trustee and Member of the Board of the Wistar Institute and the Board of Advisors of the Duke University Cancer Research Center. He served as a Director of Chimerix, Inc., February 2011. He served as LEAD Therapeutics, Inc. He was a Board Observer of CardioDx, Inc. and served as its Director since May 2009. Mr. Pappas served as a Director of AtheroGenics Inc. from June 1995 to September 10, 2008. He served as a board observer at Plexxikon of Plexxikon, Inc. He served as the Chairman of Glaxo Far East (Pte) Ltd., Glaxo Latin America Inc, and Glaxo Canada Inc. He served as a Director of Elitra Pharmaceuticals Inc. since March 2000. He served as a Director of Syntonix Pharmaceuticals, Inc. He served as Executive Member of the Board of Directors at GlaxoSmithKline Services Unlimited. He served as a member of the Medical Industry Group Advisory Board. He served as an Executive Member of the Board of Directors of Glaxo Holdings plc. Mr. Pappas served as a Director of EBM Solutions, Inc., and Embrex Inc. He served as a Director of Quintiles Transnational Corp. since September 1994. Mr. Pappas served as a Director of GeneMedicine, Inc. since January 1995, KeraVision, Inc. since January 1997, and Valentis Inc. until March 2002. He is a decorated Vietnam veteran, having served as an Officer in the United States Army 101st Airborne Division and the Special Forces. With more than 35 years guiding investment decisions in the life sciences industry, Mr. Pappas has unique business insight and financial acumen to early stage venture capital investments and to company formation, entrepreneurial and corporate development opportunities. Mr. Pappas holds an M.B.A. in Finance from Xavier University and a B.S. in Biology from the Ohio State University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.